Table 1 Patients’ characteristics
Parameters | LVAD (n = 15) | HF (n = 12) | p |
|---|---|---|---|
Age (Y) | 43 ± 4 | 47.2 ± 2.4 | 0.389 |
Men (%) | 60 | 100 | 0.013 |
BMI (Kg/m2) | 25.6 ± 1.2 | 29.1 ± 1.6 | 0.085 |
Race (caucasian) | 14 | 12 | 0.362 |
Month with HF | 51.3 ± 15 | 62 ± 20 | 0.665 |
Nonischemic HF etiology (%) | 93 | 75 | 0.183 |
NYHA class | 2.1 ± 0.1 | 2.2 ± 0.1 | 0.229 |
LVEF (%) | 24 ± 2.6 | 27 ± 2.5 | 0.540 |
Heart rate (bpm) | 88 ± 5 | 72 ± 4.6 | 0.030 |
Mean BP (mm Hg) | 104 ± 11 | 91 ± 3.7 | 0.292 |
Medications (%) | |||
 ß-blockers | 80 | 100 | 0.100 |
 ACE/ARB | 53.3 | 91.7 | 0.030 |
 Diuretic | 80 | 75 | 0.756 |
 Digitalic | 6.7 | 8.3 | 0.869 |
 Long acting nitrate | 6.7 | 8.3 | 0.869 |
 Statine | 33.3 | 50 | 0.381 |
 Antiarrhythmic | 40 | 33.3 | 0.722 |
 Oral anticoagulant | 100 | 41.7 | 0.001 |
 Anti-platelet therapy | 66.7 | 50 | 0.381 |
Underlying diseases (%) | |||
 Hypertension | 6.7 | 41.7 | 0.030 |
 Diabetes | 20 | 16.7 | 0.825 |
 Chronic renal failure | 26.7 | 16.7 | 0.535 |
 Smoker | 46.7 | 50 | 0.863 |